157 related items for PubMed ID: 10356625
1. Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients.
Mück-Seler D, Pivac N, Jakovljević M, Brzović Z.
Biol Psychiatry; 1999 Jun 01; 45(11):1433-9. PubMed ID: 10356625
[Abstract] [Full Text] [Related]
2. Platelet 5-HT and plasma cortisol concentrations after dexamethasone suppression test in patients with different time course of schizophrenia.
Jakovljević M, Mück-Seler D, Pivac N, Crncević Z.
Neuropsychobiology; 1998 Jun 01; 37(3):142-5. PubMed ID: 9597670
[Abstract] [Full Text] [Related]
3. Platelet 5-HT levels and hypothalamic-pituitary-adrenal axis activity in schizophrenic patients with positive and negative symptoms.
Pivac N, Mück-Seler D, Jakovljević M.
Neuropsychobiology; 1997 Jun 01; 36(1):19-21. PubMed ID: 9211439
[Abstract] [Full Text] [Related]
4. Hypothalamic-pituitary-adrenal axis function and platelet serotonin concentrations in depressed patients.
Pivac N, Jakovljević M, Mück-Seler D, Brzović Z.
Psychiatry Res; 1997 Dec 05; 73(3):123-32. PubMed ID: 9481804
[Abstract] [Full Text] [Related]
5. Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women.
Muck-Seler D, Pivac N, Mustapic M, Crncevic Z, Jakovljevic M, Sagud M.
Psychiatry Res; 2004 Jul 15; 127(3):217-26. PubMed ID: 15296821
[Abstract] [Full Text] [Related]
6. Monoamine oxidase and cortisol response in depression and schizophrenia.
Pandey GN, Sharma RP, Janicak PG, Davis JM.
Psychiatry Res; 1992 Oct 15; 44(1):1-8. PubMed ID: 1461943
[Abstract] [Full Text] [Related]
7. [Dexamethasone suppression test and the positive and negative symptoms of schizophrenia].
Rybakowski J, Linka M, Matkowski K, Kanarkowski R.
Psychiatr Pol; 1991 Oct 15; 25(5):9-15. PubMed ID: 1821997
[Abstract] [Full Text] [Related]
8. Dexamethasone suppression test in severe schizophrenic illness: effects of plasma dexamethasone and caffeine levels.
Holsboer-Trachsler E, Buol C, Wiedemann K, Holsboer F.
Acta Psychiatr Scand; 1987 Jun 15; 75(6):608-13. PubMed ID: 3618283
[Abstract] [Full Text] [Related]
9. Acute administration of buspirone increases the escape of hypothalamic-pituitary-adrenal-axis hormones from suppression by dexamethasone in depression.
Maes M, Van Gastel A, Meltzer HY, Cosyns P, Blockx P, Desnyder R.
Psychoneuroendocrinology; 1996 Jan 15; 21(1):67-81. PubMed ID: 8778905
[Abstract] [Full Text] [Related]
10. Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals.
Huizenga NA, Koper JW, de Lange P, Pols HA, Stolk RP, Grobbee DE, de Jong FH, Lamberts SW.
J Clin Endocrinol Metab; 1998 Jan 15; 83(1):47-54. PubMed ID: 9435415
[Abstract] [Full Text] [Related]
11. Dexamethasone suppression test in positive and negative schizophrenia.
Altamura C, Guercetti G, Percudani M.
Psychiatry Res; 1989 Oct 15; 30(1):69-75. PubMed ID: 2594873
[Abstract] [Full Text] [Related]
12. Dexamethasone suppression test in schizophrenia: its relation to monoamine metabolism in hypothalamic-pituitary-adrenal axis.
Kaneko M, Murata S, Hoshino Y, Takahagi K, Yokoyama F, Watanabe M, Kumashiro H.
Neuropsychobiology; 1989 Oct 15; 24(1):12-6. PubMed ID: 2132636
[Abstract] [Full Text] [Related]
13. Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour.
Duval F, Mokrani MC, Correa H, Bailey P, Valdebenito M, Monreal J, Crocq MA, Macher JP.
Psychoneuroendocrinology; 2001 Jul 15; 26(5):521-37. PubMed ID: 11337135
[Abstract] [Full Text] [Related]
14. HPA axis dysregulation in men with hypersexual disorder.
Chatzittofis A, Arver S, Öberg K, Hallberg J, Nordström P, Jokinen J.
Psychoneuroendocrinology; 2016 Jan 15; 63():247-53. PubMed ID: 26519779
[Abstract] [Full Text] [Related]
15. Hypothalamic-pituitary-adrenal axis in corticosteroid-resistant bronchial asthma.
Lane SJ, Atkinson BA, Swaminathan R, Lee TH.
Am J Respir Crit Care Med; 1996 Feb 15; 153(2):557-60. PubMed ID: 8564097
[Abstract] [Full Text] [Related]
16. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.
Lammers CH, Garcia-Borreguero D, Schmider J, Gotthardt U, Dettling M, Holsboer F, Heuser IJ.
Biol Psychiatry; 1995 Dec 15; 38(12):803-7. PubMed ID: 8750038
[Abstract] [Full Text] [Related]
17. The metyrapone test in schizophrenic patients and healthy subjects.
Morphy MA, Fava GA, Carson SW, Perini GI, Molnar G, Jusko WJ.
Neuropsychobiology; 1985 Dec 15; 14(1):35-8. PubMed ID: 4069347
[Abstract] [Full Text] [Related]
18. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
Tsagarakis S, Roboti C, Kokkoris P, Vasiliou V, Alevizaki C, Thalassinos N.
Clin Endocrinol (Oxf); 1998 Aug 15; 49(2):165-71. PubMed ID: 9828902
[Abstract] [Full Text] [Related]
19. Fat distribution in obese women is associated with subtle alterations of the hypothalamic-pituitary-adrenal axis activity and sensitivity to glucocorticoids.
Duclos M, Gatta B, Corcuff JB, Rashedi M, Pehourcq F, Roger P.
Clin Endocrinol (Oxf); 2001 Oct 15; 55(4):447-54. PubMed ID: 11678826
[Abstract] [Full Text] [Related]
20. Platelet MAO activity and the dexamethasone suppression test in bipolar depression.
Bagdy G, Rihmer Z, Frecska E, Szádóczky E, Arató M.
Psychoneuroendocrinology; 1986 Oct 15; 11(1):117-20. PubMed ID: 3704065
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
